Moving toward an understanding of the metastatic process in hepatocellular carcinoma - PubMed (original) (raw)

Review

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

W M Korn. World J Gastroenterol. 2001 Dec.

No abstract available

Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Li Y, et al. World J Gastroenterol. 2001 Oct;7(5):630-6. doi: 10.3748/wjg.v7.i5.630. World J Gastroenterol. 2001. PMID: 11819844 Free PMC article.

1. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer. 2001;91:2378–2385. - PubMed
1. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–1403. - PubMed
1. Ouchi K, Sugawara T, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H, Nakagawa K. Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection. J Surg Oncol. 2000;75:241–245. - PubMed
1. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507. - PubMed
1. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome. Cancer. 2000;88:538–543. - PubMed